Сравнение

Nafarelin vs. Terlipressin

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

нет данных

14636-12-5

Молекулярная масса

нет данных

1227.37 g/mol

Период полувыведения

нет данных

Последовательность

нет данных

Механизм действия

Nafarelin

Nafarelin is a potent GnRH agonist: after an initial stimulation ('flare'), continuous receptor occupancy leads to downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Terlipressin

Terlipressin is slowly converted in the body to lysine-vasopressin by cleavage of the three N-terminal glycyl residues (reservoir effect) and activates V1 receptors. The splanchnic vasoconstriction improves renal perfusion in hepatorenal syndrome.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Nafarelin	Terlipressin
Германия	Рецептурный	Рецептурный
США	Рецептурный	Рецептурный

Полные записи

Frequently asked questions

What is the difference between Nafarelin and Terlipressin?: Nafarelin is classified as "Исследования (прочее)", while Terlipressin is classified as "Исследования (прочее)". Nafarelin: Nafarelin is a GnRH agonist and the only member of this class delivered as a nasal spray. It is approved for treating endometriosis and central precocious puberty. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Nafarelin or Terlipressin?: The highest available evidence level is "РКИ на людях" for Nafarelin and "РКИ на людях" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Nafarelin and Terlipressin in Germany and the United States?: Германия: Nafarelin — Рецептурный, Terlipressin — Рецептурный. США: Nafarelin — Рецептурный, Terlipressin — Рецептурный. These are factual summaries with source and review date on the individual pages.

Country

Nafarelin

Terlipressin

Германия

Рецептурный

США

Рецептурный

Frequently asked questions

What is the difference between Nafarelin and Terlipressin?

Nafarelin is classified as "Исследования (прочее)", while Terlipressin is classified as "Исследования (прочее)". Nafarelin: Nafarelin is a GnRH agonist and the only member of this class delivered as a nasal spray. It is approved for treating endometriosis and central precocious puberty. Terlipressin: Terlipressin is a 12-amino-acid vasopressin analog and prodrug of lysine-vasopressin. As a V1 receptor agonist it is vasoconstrictive and is approved for hepatorenal syndrome (FDA 2022, Terlivaz). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Nafarelin or Terlipressin?

The highest available evidence level is "РКИ на людях" for Nafarelin and "РКИ на людях" for Terlipressin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Nafarelin and Terlipressin in Germany and the United States?

Германия: Nafarelin — Рецептурный, Terlipressin — Рецептурный. США: Nafarelin — Рецептурный, Terlipressin — Рецептурный. These are factual summaries with source and review date on the individual pages.